منابع مشابه
Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
Walsh • Focus on cardiovascular health C disease is the leading cause of death in the United States today. Fully 52% of women will die of cardiovascular disease, far exceeding the percentage who will die of all cancers combined, and far in excess of the 4% who will die of breast cancer.1 It has been known since the initial findings of the Framingham Study, however, that women have a 20-year adv...
متن کاملEstrogen replacement therapy, atherosclerosis, and vascular function.
There is strong evidence from both human and nonhuman primate studies supporting the conclusion that estrogen deficiency increases the progression of atherosclerosis. More controversial is the conclusion that postmenopausal estrogen replacement inhibits the progression of atherosclerosis. Estrogen treatment of older women (>65 years) with pre-existing coronary artery atherosclerosis had no bene...
متن کاملEstrogen-progestin replacement therapy and endometrial cancer.
BACKGROUND It has been known for more than 20 years that estrogen replacement therapy substantially increases a woman's risk of developing endometrial cancer. To reduce this increased risk, progestins have been added to estrogen replacement therapy for between 5 and 15 days (usually 7 or 10 days) per "month" in a sequential fashion (sequential estrogen-progestin replacement therapy) or with eac...
متن کاملOptimizing estrogen replacement treatment in Turner syndrome.
Estrogen has a biphasic effect on growth, stimulatory at low doses but inhibitory at higher doses. Therefore, designing optimal sex hormone replacement treatment in girls with Turner syndrome (TS) who are being treated with growth hormone (GH) involves considering the dose and form of the estrogen as well as the route and timing of its administration. We report here a preliminary analysis of a ...
متن کاملEstrogen replacement therapy in breast cancer survivors.
OBJECTIVE To determine whether estrogen replacement therapy (ERT) adversely affected outcome of breast cancer survivors. METHOD A prospective descriptive study of all breast cancer survivors who requested ERT because of intractable menopausal symptoms. All patients presented voluntarily as gynecological outpatients and were all given oral continuous opposed ERT: 20 premarin and medroxyprogest...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1994
ISSN: 0008-543X,1097-0142
DOI: 10.1002/cncr.2820741340